immediately

Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a biotech company…

6 days ago

Iridium Appoints Louis Alterman to Board of Directors

MCLEAN, Va., Dec. 4, 2025 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice, data, and…

2 weeks ago

TERREPOWER Appoints Brandon Handy as Chief People Officer

DALLAS, Dec. 2, 2025 /PRNewswire/ -- TERREPOWER today announced that Brandon Handy has been appointed Chief People Officer, effective immediately. This…

3 weeks ago

Signing Day Sports Shareholder Letter Details AI/HPC Infrastructure Opportunity with BlockchAIn Digital Infrastructure

SCOTTSDALE, AZ, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American:…

3 weeks ago

Token Cat Limited Appoints Renowned Blockchain Expert Sav Persico as Chief Operating Officer to Accelerate the Company’s Cryptocurrency and crypto Asset Transformation Strategy

BEIJING, Nov. 26, 2025 /PRNewswire/ -- Token Cat Limited (Nasdaq: TC, the "Company") today announced the appointment of Sav Persico…

4 weeks ago

Vehere Elevates Sanjay Bhardwaj to Managing Director, India and ASEAN

NEW DELHI, Sept. 12, 2025 /PRNewswire/ -- Vehere, a leader in AI-powered Cyber Network Intelligence, proudly announces the promotion of Sanjay…

3 months ago

Nilesh Shah joins Illumina as Head of Region, AMEA

SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced…

4 months ago

SimCorp names Peter Sanderson as Chief Executive Officer

Sanderson has proven track record of driving growth and deep industry knowledge Sanderson has held key leadership roles at GAM Investments,…

5 months ago

A New Chapter of Bold Leadership and Unstoppable Growth

LEHI, Utah, July 24, 2025 /PRNewswire/ -- Amare Global, The Mental Wellness Company™, is pleased to announce a powerful new…

5 months ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…

6 months ago